Results 121 to 130 of about 134,651 (307)

Vulvar hidradenoma papilliferum: A case report including dermatologic and histopathologic findings

open access: yes
International Journal of Gynecology &Obstetrics, EarlyView.
Amelia Srajer   +2 more
wiley   +1 more source

Sustainability of regular use of interdental cleaning tools in periodontally healthy individuals

open access: yesJournal of Periodontology, EarlyView.
Abstract Background The aim of this study was to compare the sustainability of regular use of 2 different interdental cleaning tools in 24 weeks by periodontally healthy individuals as a component of primary prevention. Methods Periodontally healthy individuals were randomly assigned to dental floss or rubber interdental pick group.
Mert Yılmaz   +2 more
wiley   +1 more source

A Spectrophotometric Method to Determine Minimal Erythema Dose for Ultraviolet Radiation in Human Skin

open access: yesBiomedicines
Background/Objectives: Ultraviolet radiation (UVR) induces oxidative stress in the skin by generating reactive oxygen species (ROS), which can lead to inflammatory conditions including erythema (a sign of sunburn).
Eun Ju Lee   +4 more
doaj   +1 more source

AO/AAP consensus on prevention and management of peri‐implant diseases and conditions: Summary report

open access: yesJournal of Periodontology, EarlyView.
Abstract Background The exponential increase in dental implant use has led to a parallel rise in peri‐implant diseases (PID), adversely affecting implant therapy success and patient quality of life. Efforts have been made by the dental community to understand systemic, behavioral, and site‐level risk factors involved in the etiologies and pathogenesis ...
Hom‐Lay Wang   +15 more
wiley   +1 more source

Have we hit the JAK‐pot? Success of selective JAK 1 inhibitor following failure of pan‐JAK inhibitor in refractory pediatric ulcerative colitis

open access: yesJPGN Reports, EarlyView.
Abstract The treatment options available for pediatric ulcerative colitis (UC) are challenging due to few with Federal Drug Administration approval. Newer medications approved for adults include additional biologics with differing mechanisms of action and small molecule drugs, such as Janus kinase (JAK) inhibitors.
Jessica A. Black, Brad Pasternak
wiley   +1 more source

Home - About - Disclaimer - Privacy